ATM
Aneka Tambang (Persero) Tbk (Pt)
🇦🇺 ASX
🍃 HIGH ESG SCORE
🌳 ENVIRONMENTAL
🕊️ SOCIALLY AWARE
⛏️ MINING
👑 Overview
📈 Performance
💰 Dividends
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
-1.20%
Annual Growth
5 years average annual growth
💰
4.47%
Annual dividend yield
Based on the most recent dividend
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
0
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
PT Aneka Tambang Tbk engages in the exploration, exploitation, processing, refining, and marketing of minerals, precious metals, and coal. The company is headquartered in Jakarta Selatan, Dki Jakarta and currently employs 3,815 full-time employees. The company is engaged in the business of mining various types of minerals, and of mining-related industry, trade, transportation, and mining sector services. The firm operates through three segments: Nickel, Precious Metals and Refinery, and Bauxite and Alumina. Its Nickel segment is comprised of ferronickel and nickel ore sales. Its Precious Metals and Refinery business segment consists of gold commodity, silver and precious metals processing and refinery services. Its gold ore mining is produced from two mining sites: Pongkor, West Java and Cibaliung, Banten. Bauxite contains alumina (AI203) and a mixture of silica, various iron oxides, and titanium dioxide. The company has three ferronickel smelters (FeNi II, III and IV) with four production lines with annual combined capacity of 27,000 tons. The Company, through its subsidiary, PT Indonesia Coal Resources, produces coal from the Sarolangun coal mine located in Jambi Province, Indonesia.
📈 Performance
Price History
-14.55%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💰 Dividends
Payouts
💰 Annual Dividend Yield*
4.47%
💰 Annual Dividend Earnings Per $1,000 invested**
$44.71
💰 Most Recent Dividend Franked Percentage Estimate
0.00%
💰 Average Dividend Franked Percentage Estimate
0.00 %
💰 Dividend reinvestment
* Based on the most recent dividend
** Calculated by multiplying the most recent dividend yield by $1,000
Estimate your dividend
If you held
$
of ATM, your last dividend payment(s) would have been:
$ 447.06
on Fri Jun 07 2024
$ 288.82
on Fri Jul 14 2023
*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.
Dividend History
1Y
5Y
10Y
Graph
Table
Year
Yearly Dividend Earnings Per Share
Franking Estimate
2024
$0.00
0.00%
2023
$0.03
NaN%
2022
$0.01
NaN%
2021
$0.01
NaN%
2020
$0.00
NaN%
2019
$0.01
NaN%
2018
$0.00
0.00%
2017
$0.00
0.00%
2016
$0.00
0.00%
2015
$0.00
0.00%
💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🍃 Environmental, Social and Governance scores ℹ️
🌳
Environmental Score
99
A measure of an organisations or investment's impact on the natural environment, including factors such as carbon emissions, resource usage, and pollution
⚖️
Governance Score
81
An evaluation of an organisations impact on society, focusing on factors such as employee welfare, diversity and inclusion, community engagement, and product safety and quality.
🤓 Advanced information
Technical Info
💰 Price*
$0.94
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in ATM
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in ATM
N/A
ATM investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in ATM also invest in...
Want more shares? Try these...
ATOM.AX was created on 2022-12-07 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Global Uranium & Nuclear Components Total Return Index
📊 Share price
$15.35 AUD
⚡️ ENERGY
Atlas Pearls Ltd. produces white & silver South Sea pearls and farming operations in Indonesia. The company is headquartered in Perth, Western Australia. The firm is a producer of South Sea pearls, specializing in white and silver pearls. The firm operates approximately seven pearl farms throughout the Indonesian archipelago, from the national park lands of Banyu Biru to Flores, and as far east as West Papua. The firm is a fully integrated business including hatchery, seeding, harvesting, grading, trading, design and manufacturing capabilities to sell directly to customers through wholesale partners and via its retail outlets. The firm provides a range of products, such as DOUBLE PEARL BRACELET, CAGE PENDANT, KESHI STUDS, VINE RING, SIMPLE SHEPHERD HOOK EARRINGS, TOP HAT PENDANT, SICKLE PEARL RING, NEOPRENE PEARL BRACELET, FLAT BUTTON STUDS, BUBBLED RING, NEOPRENE PEARL BRACELET, FIXED PENDANT, FILAGREE CUP STUD, FLOWER FILAGREE PENDANT, PAVED DIAMOND PENDANT, OPEN PETAL RING, SIMPLE SHEPHERD HOOK EARRINGS and CAGE PENDANT.
🙌 Performance (5Yr p.a)
313.33%
📊 Share price
$0.15 AUD
🛍️ CONSUMER
Alterity Therapeutics Ltd. is a clinical stage biotechnology company. The company is headquartered in Melbourne, Victoria and currently employs 10 full-time employees. The company went IPO on 2000-03-28. The firm is focused on developing disease modifying treatments for neurodegenerative diseases. The firm's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. The company has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The firm also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase II clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.
🙌 Performance (5Yr p.a)
-15.00%
📊 Share price
$0.01 AUD
🧬 BIOTECHNOLOGY
🕊️
Social Score
99
An assessment of an organisations management practices, board structure, transparency, and accountability, reflecting its commitment to ethical behavior and responsible decision-making.